7M22 image
Entry Detail
PDB ID:
7M22
EMDB ID:
Title:
Cryo-EM structure of the HCMV pentamer bound by human neuropilin 2
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2021-03-15
Release Date:
2021-08-11
Method Details:
Experimental Method:
Resolution:
3.65 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Envelope protein UL128
Chain IDs:A (auth: C)
Chain Length:144
Number of Molecules:1
Biological Source:Human cytomegalovirus
Polymer Type:polypeptide(L)
Description:Envelope glycoprotein UL130
Chain IDs:B (auth: D)
Chain Length:189
Number of Molecules:1
Biological Source:Human cytomegalovirus
Polymer Type:polypeptide(L)
Description:UL131A
Chain IDs:C (auth: E)
Chain Length:111
Number of Molecules:1
Biological Source:Human cytomegalovirus
Polymer Type:polypeptide(L)
Description:Neuropilin-2
Chain IDs:D (auth: N)
Chain Length:581
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodies.
Sci Adv 8 eabm2546 eabm2546 (2022)
PMID: 35275718 DOI: 10.1126/sciadv.abm2546

Abstact

Human cytomegalovirus (HCMV) encodes multiple surface glycoprotein complexes to infect a variety of cell types. The HCMV Pentamer, composed of gH, gL, UL128, UL130, and UL131A, enhances entry into epithelial, endothelial, and myeloid cells by interacting with the cell surface receptor neuropilin 2 (NRP2). Despite the critical nature of this interaction, the molecular determinants that govern NRP2 recognition remain unclear. Here, we describe the cryo-EM structure of NRP2 bound to Pentamer. The high-affinity interaction between these proteins is calcium dependent and differs from the canonical carboxyl-terminal arginine (CendR) binding that NRP2 typically uses. We also determine the structures of four neutralizing human antibodies bound to the HCMV Pentamer to define susceptible epitopes. Two of these antibodies compete with NRP2 binding, but the two most potent antibodies recognize a previously unidentified epitope that does not overlap the NRP2-binding site. Collectively, these findings provide a structural basis for HCMV tropism and antibody-mediated neutralization.

Legend

Protein

Chemical

Disease

Primary Citation of related structures